Innospec - IOSP Stock Forecast, Price & News

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Innospec in the last year. There are currently 1 hold rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" IOSP shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in IOSP, but not buy additional shares or sell existing shares.
View IOSP analyst ratings or view top-rated stocks.

Innospec's stock was trading at $102.86 at the start of the year. Since then, IOSP stock has increased by 7.9% and is now trading at $110.98.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Tuesday, February 21st 2023.
View our IOSP earnings forecast.

Innospec will be holding an earnings conference call on Wednesday, February 22nd at 9:00 AM Eastern. Interested parties can register for or listen to the call using this link.

Innospec Inc. (NASDAQ:IOSP) released its quarterly earnings data on Tuesday, November, 8th. The specialty chemicals company reported $1.74 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.40 by $0.34. The specialty chemicals company earned $513 million during the quarter, compared to the consensus estimate of $468.35 million. Innospec had a trailing twelve-month return on equity of 14.37% and a net margin of 7.04%.

Innospec announced a Semi-Annual dividend on Tuesday, November 8th. Stockholders of record on Monday, November 21st will be paid a dividend of $0.65 per share on Monday, November 28th. This represents a dividend yield of 1.2%. The ex-dividend date of this dividend is Friday, November 18th. This is a boost from the stock's previous Semi-Annual dividend of $0.63.
Read our dividend analysis for IOSP.

Innospec (NASDAQ:IOSP) pays an annual dividend of $1.30 per share and currently has a dividend yield of 1.18%. The company has been increasing its dividend for 2 consecutive year(s), indicating that it does not yet have a strong track record of dividend growth. The dividend payout ratio is 24.71%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, IOSP will have a dividend payout ratio of 19.73% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for IOSP.

12 employees have rated Innospec Chief Executive Officer Patrick S. Williams on Glassdoor.com. Patrick S. Williams has an approval rating of 96% among the company's employees. This puts Patrick S. Williams in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Innospec investors own include NVIDIA (NVDA), Altria Group (MO), Ecolab (ECL), Eastman Chemical (EMN), Corning (GLW), Realty Income (O), Pfizer (PFE), Sherwin-Williams (SHW), Weyerhaeuser (WY) and Applied Materials (AMAT).

Innospec trades on the NASDAQ under the ticker symbol "IOSP."

Innospec's stock is owned by many different retail and institutional investors. Top institutional investors include Allspring Global Investments Holdings LLC (9.87%), Kirr Marbach & Co. LLC IN (0.32%), ZWJ Investment Counsel Inc. (0.17%), Yousif Capital Management LLC (0.07%), Comerica Bank (0.06%) and Assenagon Asset Management S.A. (0.06%). Insiders that own company stock include Brian Watt, Catherine Hessner, David B Jones, David Landless, Ian Cleminson, Ian Malcolm Mcrobbie, Milton C Blackmore, Patrick Williams and Philip John Boon.
View institutional ownership trends.

Shares of IOSP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of IOSP stock can currently be purchased for approximately $110.98.

Innospec (NASDAQ:IOSP) has a market capitalization of $2.75 billion and generates $1.48 billion in revenue each year. The specialty chemicals company earns $93.10 million in net income (profit) each year or $5.26 on an earnings per share basis.

The company employs 1,900 workers across the globe.

Innospec's mailing address is 8310 SOUTH VALLEY HIGHWAY SUITE 350, ENGLEWOOD CO, 80112. The official website for the company is www.innospecinc.com. The specialty chemicals company can be reached via phone at (303) 792-5554, via email at brian.watt@innospecinc.com, or via fax at 303-792-5668.